AAAAAA

   
Results: 1-9 |
Results: 9
Serum pharmacokinetics and sputum penetration of amikacin 30 mg/kg once daily and of ceftazidime 200 mg/kg/day as a continuous infusion in cystic fibrosis patients
Authors: Byl, B Baran, D Jacobs, F Herschuelz, A Thys, JP
Citation: B. Byl et al., Serum pharmacokinetics and sputum penetration of amikacin 30 mg/kg once daily and of ceftazidime 200 mg/kg/day as a continuous infusion in cystic fibrosis patients, J ANTIMICRO, 48(2), 2001, pp. 325-327
Fatal primary infection due to human herpesvirus 6 variant A in a renal transplant recipient
Authors: Rossi, C Delforge, ML Jacobs, F Wissing, M Pradier, O Remmelink, M Byl, B Thys, JP Liesnard, C
Citation: C. Rossi et al., Fatal primary infection due to human herpesvirus 6 variant A in a renal transplant recipient, TRANSPLANT, 71(2), 2001, pp. 288-292
Impact of infectious diseases specialists - Reply
Authors: Byl, B Thys, JP
Citation: B. Byl et Jp. Thys, Impact of infectious diseases specialists - Reply, CLIN INF D, 30(5), 2000, pp. 838-839
Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia
Authors: Byl, B Clevenbergh, P Jacobs, F Struelens, MJ Zech, F Kentos, A Thys, JP
Citation: B. Byl et al., Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia, CLIN INF D, 29(1), 1999, pp. 60-66
Penetration of meropenem in lung, bronchial mucosa, and pleural tissues
Authors: Byl, B Jacobs, F Roucloux, I de Franquen, P Cappello, M Thys, JP
Citation: B. Byl et al., Penetration of meropenem in lung, bronchial mucosa, and pleural tissues, ANTIM AG CH, 43(3), 1999, pp. 681-682
Single cell analysis of antigen-specific T cell responses in HIV-infected individuals
Authors: Byl, B Gerard, M Libin, M Clumeck, N Goodman, M Mascart, F
Citation: B. Byl et al., Single cell analysis of antigen-specific T cell responses in HIV-infected individuals, CELL IMMUN, 192(2), 1999, pp. 107-112
Consensus statement on the treatment of septic shock
Authors: Spapen, H Damas, P D'Orio, V Sabbe, R Vogelaers, D Byl, B Knockaert, D
Citation: H. Spapen et al., Consensus statement on the treatment of septic shock, ACT CLIN B, 54(5), 1999, pp. 256-262
GDEPIH-GOSPIZ Belgian consensus strategies to control antibiotic-resistantbacteria in hospitals
Authors: Colardijn, F Damas, P De Mol, P Glupczynski, Y Gordus, B Ronveaux, O Struelens, M Thys, JP Verhaegen, J Vogelaers, D Wilmotte, L Bossens, M Byl, B Carpentier, M Claeys, G Crokaert, F Daux, J Dediste, A De Jongh, D Delporte, JP Desmet, F d'Hollander, A Ezzedine, H Fameree, D Garrino, M Goossens, H Govaerts, D Hecq, JD Ieven, G Jacobs, F Jordens, P Larbuisson, W Laterre, PF Lauwers, S Lefebure, B Lievin, V Meert, P Melin, P Mertens, A Moulin, D Peetermans, W Peleman, R Potvliege, C Reynaert, M Rost, F Simon, A Sion, JP Stuyck, J Valcke, Y Van Beek, F Vandercam, B Van Laethem, Y Van Landuyt, H Van Vooren, JP Van Wyngaarden, E Verbist, L Verschraegen, G Vincent, JL Wauters, G Willems, L
Citation: F. Colardijn et al., GDEPIH-GOSPIZ Belgian consensus strategies to control antibiotic-resistantbacteria in hospitals, ACT CLIN B, 54(1), 1999, pp. 15-16
The patient with intravascular lines
Authors: Byl, B
Citation: B. Byl, The patient with intravascular lines, ACT CLIN B, 53(6), 1998, pp. 355-359
Risultati: 1-9 |